Banner

Study finds children with residual amblyopia did not find an advantage with levodopa

Article

A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA.

Baltimore-A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA. 

 

Read the results of the study here.

Related Videos
Lyndon Jones, PhD, DSc, FCOptom, FAAO
© 2023 MJH Life Sciences

All rights reserved.